By the end of this chapter you'll be able to…

  • 1Predict the likely fungal infection from the host immune defect described in a stem
  • 2Explain why ergosterol confers both selectivity and toxicity on antifungal drugs
  • 3Distinguish Aspergillus from the Mucorales on hyphal morphology and branching angle
  • 4State the limitations of beta-D-glucan and galactomannan testing
  • 5Explain why scalp and nail dermatophytosis require systemic therapy
  • 6Account for the rise of resistant dermatophytosis in India and recognise tinea incognito
  • 7Identify the subcutaneous mycoses and explain why grain colour in mycetoma changes treatment
  • 8Explain the iron mechanism linking diabetic ketoacidosis to mucormycosis
  • 9Distinguish Candida species by their susceptibility and explain the significance of Candida auris
  • 10Explain why Pneumocystis responds to co-trimoxazole rather than to conventional antifungals
💡
Why this chapter matters in NEET PG
Most pathogenic fungi are environmental organisms of low intrinsic virulence, and what determines whether one causes a trivial rash or a fatal invasive infection is which host defence has failed. Neutrophils control moulds and T cells control yeasts and intracellular fungi, so identifying the immune defect in a stem predicts the fungal infection more reliably than knowing the organism does. That host-centred logic is the organising principle of the whole subject.

Mycology

1. What this chapter covers, and how NEET PG actually tests it

Mycology is a small subject that carries more marks than its size suggests, because fungal infections cluster in the immunocompromised patients the exam likes to describe.

The organising principle is that the host, not the fungus, decides the disease.

Most pathogenic fungi are environmental organisms of low intrinsic virulence. What determines whether they cause a trivial rash or a fatal invasive infection is which host defence has failed.

DefectCharacteristic fungal infection
NeutropeniaInvasive aspergillosis, candidaemia, mucormycosis
T cell deficiencyCryptococcus, Pneumocystis, endemic mycoses
Diabetes with ketoacidosisMucormycosis
Skin barrier breachCandida, dermatophytes
Indwelling catheterCandidaemia

Neutrophils control moulds and T cells control yeasts and intracellular fungi, which is why the pattern in the table is so consistent and why it can be reasoned rather than memorised.

2. Fundamentals

2.1 Structure and classification

Fungi are eukaryotes with a chitin cell wall and an ergosterol-containing membrane, and both are the targets of antifungal drugs.

Ergosterol occupies the place cholesterol holds in human membranes, which is why azoles and amphotericin are selective but not perfectly so, and why their toxicity profiles are what they are.

Yeasts are single cells reproducing by budding; moulds grow as filamentous hyphae; dimorphic fungi are moulds in the environment and yeasts in tissue.

The dimorphic rule is worth stating explicitly: mould at ambient temperature, yeast at body temperature.

Septate hyphae branching at acute angles indicate Aspergillus, while broad aseptate hyphae branching at right angles indicate the Mucorales.

That single morphological distinction separates two invasive mould infections with very different treatments.

2.2 Laboratory identification

Potassium hydroxide mount dissolves keratin and reveals fungal elements in skin, hair and nail samples.

Sabouraud dextrose agar is the standard culture medium, its low pH suppressing bacterial growth.

India ink demonstrates the cryptococcal capsule as a clear halo, though antigen testing has largely replaced it.

Calcofluor white binds chitin and fluoresces, and periodic acid-Schiff and Gomori methenamine silver are the tissue stains.

Galactomannan and beta-D-glucan are circulating fungal cell wall antigens used to detect invasive disease before culture becomes positive.

Beta-D-glucan is present in most fungi but absent from the Mucorales and from Cryptococcus, which is why a negative result does not exclude those two.

3. Superficial and cutaneous mycoses

3.1 Dermatophytes

Three genera cause dermatophytosis: Trichophyton, Microsporum and Epidermophyton.

They digest keratin and are therefore confined to skin, hair and nails, which is why invasive dermatophyte disease essentially does not occur in immunocompetent people.

SiteName
ScalpTinea capitis
BodyTinea corporis
GroinTinea cruris
FootTinea pedis
NailTinea unguium or onychomycosis

Topical treatment suffices for most sites but fails for scalp and nail, because the fungus resides within the hair shaft and nail plate where topical agents cannot penetrate.

Oral terbinafine or itraconazole is therefore required for those two sites, and griseofulvin remains useful in tinea capitis in children.

Recurrent and treatment-resistant dermatophytosis has become a substantial problem in India, associated with over-the-counter topical steroid-antifungal combinations that suppress inflammation while allowing the fungus to spread.

Tinea incognito is the resulting atypical presentation, in which steroid use has removed the characteristic raised active edge.

Trichophyton indotineae has been identified as a distinct terbinafine-resistant species behind much of this, carrying mutations in the squalene epoxidase gene that terbinafine targets.

That is a resistance mechanism of exactly the kind seen in bacteria: alteration of the drug's target, rendering the whole class less effective.

3.2 Other superficial infections

Malassezia furfur causes pityriasis versicolor with hypopigmented or hyperpigmented macules, and shows a spaghetti and meatballs appearance of short hyphae and spores on microscopy.

It is lipophilic, which explains its distribution over sebum-rich areas and its association with the neonatal use of lipid infusions.

Candida causes oral thrush, intertrigo, vulvovaginitis and nappy rash, and is favoured by moisture, antibiotics, diabetes and steroid use.

Oral thrush in an adult with no obvious local cause should prompt consideration of HIV or another immunodeficiency, since it is otherwise unusual outside infancy and denture use.

3.3 Subcutaneous mycoses

These occupy the middle ground: acquired by traumatic inoculation, spreading locally, but not disseminating in immunocompetent hosts.

They matter disproportionately in India because they follow barefoot agricultural work and thorn injuries.

Mycetoma presents as a chronic swelling with multiple discharging sinuses containing visible grains, and the grain colour narrows the cause.

Eumycetoma is fungal with black grains typically, while actinomycetoma is bacterial with pale or red grains, and the distinction matters because actinomycetoma responds to antibiotics while eumycetoma often needs surgery.

That is a rare instance where a clinical appearance decides between antibacterial and antifungal therapy.

Sporotrichosis follows a thorn prick, classically from rose gardening, and spreads along lymphatics producing a chain of nodules.

That linear lymphocutaneous pattern is characteristic enough to be called sporotrichoid spread, and potassium iodide or itraconazole is used.

Chromoblastomycosis produces verrucous plaques with sclerotic bodies visible on histology, and rhinosporidiosis produces friable nasal polyps and is associated with pond bathing.

4. Systemic and opportunistic mycoses

4.1 The endemic dimorphic fungi

FungusGeographyFeature
Histoplasma capsulatumOhio and Mississippi valleys, also IndiaIntracellular in macrophages, bird and bat droppings
BlastomycesNorth AmericaBroad-based budding
CoccidioidesSouthwestern United StatesSpherules with endospores
ParacoccidioidesLatin AmericaPilot-wheel budding
Talaromyces marneffeiSoutheast AsiaHIV-associated, bamboo rat reservoir

These fungi cause self-limiting pulmonary disease in healthy people and disseminated disease in the immunosuppressed, which is the host principle again.

Histoplasmosis is endemic in parts of India, particularly the Gangetic plain, and disseminated disease presents with fever, hepatosplenomegaly and pancytopenia.

Histoplasma survives inside macrophages rather than being killed by them, which is why it behaves like an intracellular pathogen and why intact cell-mediated immunity is what controls it.

The consequence is that disseminated histoplasmosis clusters in advanced HIV and in patients on anti-TNF therapy, and that it can reactivate years after the original exposure.

Coccidioidomycosis is notable for producing erythema nodosum, sometimes called desert rheumatism, which represents a vigorous immune response and paradoxically indicates a good prognosis.

Talaromyces marneffei is the one dimorphic fungus that causes disease chiefly in HIV, and it is essentially confined to Southeast Asia and adjacent parts of northeast India.

4.2 Cryptococcus

Cryptococcus neoformans is an encapsulated yeast acquired by inhalation, with pigeon droppings as the classical source.

Its polysaccharide capsule is the principal virulence factor, inhibiting phagocytosis.

Cryptococcal meningitis is the archetypal T cell deficiency infection, occurring almost exclusively at CD4 counts below one hundred.

Cryptococcal antigen testing on serum or cerebrospinal fluid is more sensitive than India ink and is the preferred diagnostic method.

Raised intracranial pressure is a major cause of death and requires repeated therapeutic lumbar puncture, which is as important as the antifungal therapy itself.

Treatment is amphotericin B with flucytosine for induction, followed by fluconazole.

4.3 The invasive moulds

Aspergillus produces a spectrum determined entirely by host immunity.

Allergic bronchopulmonary aspergillosis occurs in asthma and cystic fibrosis with raised IgE and eosinophilia; aspergilloma colonises an existing cavity; invasive aspergillosis occurs in neutropenia.

The same organism therefore produces an allergic disease, a colonising mass and a fatal invasive infection, depending only on the host.

Mucormycosis is caused by the Mucorales and is characteristically angioinvasive, producing tissue infarction and the black necrotic eschar of rhino-orbital-cerebral disease.

Diabetic ketoacidosis is the classic predisposing state, because acidosis releases iron from transferrin and the organism requires free iron to grow.

Treatment demands urgent surgical debridement alongside amphotericin B, since dead infarcted tissue cannot be reached by any drug.

Deferoxamine therapy paradoxically worsens mucormycosis, because the organism uses the iron-chelator complex as a siderophore and takes up the iron it delivers.

That observation is what established the central role of iron availability in the disease, and it is why iron chelation is avoided in patients at risk.

India saw a sharp rise in mucormycosis during the COVID-19 pandemic, driven by the combination of corticosteroid therapy, uncontrolled diabetes and the illness itself.

That surge illustrates the chapter's principle exactly: the organism had not changed, but a large population suddenly acquired the specific host defect it exploits.

Pneumocystis jirovecii causes pneumonia at CD4 counts below two hundred, with dry cough, exertional desaturation and diffuse infiltrates, and is treated with co-trimoxazole.

Adjunctive corticosteroids are given when hypoxaemia is significant, because killing the organism releases antigen and transiently worsens inflammation.

Pneumocystis is worth noting as a fungus that behaves like a protozoan, which is why it was classified as one for decades and why it responds to co-trimoxazole rather than to conventional antifungals.

It lacks ergosterol in its membrane, which is precisely why amphotericin and the azoles do not work against it.

Diagnosis rests on induced sputum or bronchoalveolar lavage with silver or immunofluorescent staining, since the organism cannot be cultured.

A raised serum lactate dehydrogenase and beta-D-glucan support the diagnosis, and prophylaxis with co-trimoxazole is given below a CD4 count of two hundred.

4.4 Candida: species matter

Candida albicans remains the commonest species but the non-albicans species now account for a large share of invasive disease, and they differ in susceptibility.

Germ tube formation in serum at 37 degrees identifies Candida albicans, and chlamydospore production on cornmeal agar confirms it.

SpeciesPractical significance
C. albicansGerm tube positive, generally azole-sensitive
C. glabrataReduced azole susceptibility
C. kruseiIntrinsically fluconazole-resistant
C. parapsilosisCatheter and prosthetic association, reduced echinocandin susceptibility
C. aurisMultidrug-resistant, persists on surfaces, causes outbreaks

Candida krusei is intrinsically fluconazole-resistant, which is why empirical fluconazole is inappropriate where it is likely.

Candida auris deserves separate mention because it behaves more like a resistant bacterium than a typical fungus: it colonises skin, survives on hospital surfaces, resists routine disinfection, and is frequently resistant to multiple antifungal classes.

It is also frequently misidentified by conventional laboratory methods, which is part of why it spreads before being recognised.

Candidaemia requires removal of any indwelling line, since the organism forms biofilm that no antifungal will penetrate, and ophthalmological assessment because endophthalmitis is a recognised complication.

A positive blood culture for Candida is never treated as a contaminant, unlike coagulase-negative staphylococci, because the mortality of untreated candidaemia is high.

5. Antifungal therapy

5.1 Matching drug to target

ClassTargetKey point
Amphotericin BBinds ergosterol, forms poresNephrotoxicity, potassium and magnesium wasting
AzolesInhibit lanosterol 14-alpha-demethylaseInhibit human cytochrome P450
EchinocandinsInhibit beta-glucan synthesisTarget absent in humans, well tolerated
FlucytosineConverted to 5-fluorouracil in fungusMarrow suppression
TerbinafineInhibits squalene epoxidaseOral agent for onychomycosis
GriseofulvinDisrupts microtubulesTinea capitis in children

The echinocandins are so well tolerated because beta-glucan has no human counterpart at all, unlike ergosterol which resembles cholesterol.

That structural similarity between ergosterol and cholesterol is also why amphotericin causes the toxicity it does.

Azoles inhibit human cytochrome P450 as a direct consequence of the enzyme they were designed to inhibit, which is why azole interactions are so extensive.

5.2 Why antifungals are harder than antibacterials

Antifungal development is intrinsically more difficult than antibacterial development, and the reason explains the whole shape of the drug list.

Fungi are eukaryotes, so they share most of their cellular machinery with human cells, leaving very few targets that exist in the fungus and not in us.

Bacteria are prokaryotes with a completely different ribosome, a peptidoglycan wall and distinct metabolic pathways, which offers many more points of selective attack.

That is why there are only four main antifungal classes against dozens of antibacterial ones, and why the antifungals that do exist tend to be more toxic.

It also explains why the best-tolerated class, the echinocandins, targets the one structure with no human equivalent at all.

Resistance is a growing problem, driven partly by agricultural azole fungicide use selecting for azole-resistant Aspergillus in the environment.

That environmental route means a patient can acquire an azole-resistant strain without ever having taken an azole, which is a genuine departure from the usual model of resistance.

5.3 Choosing between them

Amphotericin remains first-line for mucormycosis and for cryptococcal induction, and echinocandins do not work against either Cryptococcus or the Mucorales.

Fluconazole penetrates cerebrospinal fluid well and is used for cryptococcal consolidation and maintenance.

Voriconazole is preferred for invasive aspergillosis and characteristically causes transient visual disturbance.

Echinocandins are first-line for candidaemia, particularly where azole resistance is a concern.

They are a poor choice for urinary candidiasis, however, because they achieve very low urinary concentrations, and fluconazole is preferred there.

Flucytosine is never given alone, because resistance emerges rapidly during monotherapy, which is why it always appears in combination with amphotericin.

Liposomal amphotericin reduces nephrotoxicity substantially but does not eliminate the infusion reactions, and it is considerably more expensive.

Pre-medication and saline loading reduce those two problems with conventional amphotericin, which is why they remain routine practice.

6. Worked examples

Example 1

A patient in diabetic ketoacidosis develops facial pain, black nasal discharge and a necrotic palatal eschar.

The combination of ketoacidosis and a black necrotic eschar is close to diagnostic.

Mucorales are angioinvasive, thrombosing vessels and infarcting the tissue they occupy, which is what produces the eschar.

Acidosis releases iron from transferrin, and the organism requires free iron to grow, which is why ketoacidosis specifically rather than diabetes alone is the risk factor.

Management is urgent surgical debridement plus amphotericin B, and debridement is essential because infarcted tissue has no blood supply to deliver the drug.

Example 2

A man with HIV and a CD4 count of 40 has headache and fever. Cerebrospinal fluid opening pressure is markedly raised.

A CD4 count below one hundred with subacute meningitis points strongly to Cryptococcus.

The polysaccharide capsule inhibits phagocytosis, which is why intact T cell function is required to contain the organism.

The raised opening pressure is not incidental and is a major cause of death, requiring repeated therapeutic lumbar puncture alongside antifungal therapy.

Cryptococcal antigen testing is more sensitive than India ink, and induction treatment is amphotericin B with flucytosine.

Example 3

A child with tinea capitis is treated with topical antifungal cream without improvement.

Dermatophytes digest keratin, and in tinea capitis the organism lies within the hair shaft itself.

Topical agents cannot penetrate into the hair shaft, which is why scalp and nail infections both fail topical treatment while body and groin infections respond well.

Systemic therapy is required, with griseofulvin or terbinafine depending on the species and local practice.

The same reasoning explains why onychomycosis requires prolonged oral therapy rather than topical lacquer alone in most cases.

7. Traps the exam sets repeatedly

Treating tinea capitis or onychomycosis topically. The organism sits where topical agents cannot reach.

Using an echinocandin for cryptococcal or mucormycotic infection. Neither organism is susceptible.

Relying on beta-D-glucan to exclude invasive fungal disease. It is negative in Mucorales and Cryptococcus infection.

Treating mucormycosis medically alone. Infarcted tissue receives no drug, so debridement is essential.

Assuming aspergillosis means invasive disease. The same organism causes allergic, colonising and invasive disease depending on the host.

Using an azole or amphotericin for Pneumocystis. It lacks ergosterol, so both are useless; co-trimoxazole is the treatment.

Dismissing a blood culture growing Candida as a contaminant. Candidaemia is never a contaminant and carries high mortality untreated.

Prescribing empirical fluconazole where Candida krusei is likely. It is intrinsically resistant to fluconazole.

Summary

The host rather than the fungus decides the disease, and identifying the failed defence predicts the infection.

Neutrophils control moulds and T cells control yeasts and intracellular fungi.

Ergosterol resembles cholesterol, which explains both the selectivity and the toxicity of the ergosterol-targeting drugs.

Acute-angle septate hyphae indicate Aspergillus; right-angle aseptate hyphae indicate the Mucorales.

Beta-D-glucan is negative in Mucorales and Cryptococcus infection, so it cannot exclude them.

Dermatophytes are confined to keratin, and scalp and nail infections require systemic therapy.

Topical steroid-antifungal combinations have driven resistant dermatophytosis in India and produce tinea incognito.

Cryptococcal meningitis occurs below a CD4 count of one hundred, and raised intracranial pressure must be treated alongside the infection.

Diabetic ketoacidosis predisposes to mucormycosis because acidosis liberates the free iron the organism needs.

Echinocandins are exceptionally well tolerated because beta-glucan has no human counterpart.

Subcutaneous mycoses follow traumatic inoculation, and grain colour in mycetoma decides between antibacterial and antifungal treatment.

Candida species differ in susceptibility, with krusei intrinsically fluconazole-resistant and auris multidrug-resistant.

Pneumocystis lacks ergosterol, which is why it responds to co-trimoxazole rather than to conventional antifungals.

Antifungals are few and relatively toxic because fungi are eukaryotes sharing most cellular machinery with us.

Key formulas & results

Everything to memorise for the exam hall, in one card. Screenshot this for revision.

The organising principle
THE HOST, NOT THE FUNGUS, DECIDES THE DISEASE. NEUTROPENIA: invasive aspergillosis, candidaemia, mucormycosis. T CELL DEFICIENCY: Cryptococcus, Pneumocystis, endemic mycoses. DIABETIC KETOACIDOSIS: mucormycosis. SKIN BARRIER BREACH: Candida, dermatophytes. INDWELLING CATHETER: candidaemia.
NEUTROPHILS CONTROL MOULDS AND T CELLS CONTROL YEASTS AND INTRACELLULAR FUNGI, which is why the pattern is so consistent and can be reasoned rather than memorised.
Structure and the basis of drug selectivity
Fungi are EUKARYOTES with a CHITIN cell wall and an ERGOSTEROL-containing membrane — both are drug targets. YEASTS bud as single cells; MOULDS grow as hyphae; DIMORPHIC fungi are MOULD AT AMBIENT TEMPERATURE, YEAST AT BODY TEMPERATURE.
ERGOSTEROL OCCUPIES THE PLACE CHOLESTEROL HOLDS IN HUMAN MEMBRANES, which is why azoles and amphotericin are selective BUT NOT PERFECTLY SO, and why their toxicity profiles are what they are.
Hyphal morphology separates the invasive moulds
SEPTATE hyphae branching at ACUTE ANGLES: ASPERGILLUS. BROAD ASEPTATE hyphae branching at RIGHT ANGLES: MUCORALES.
That single morphological distinction separates two invasive mould infections with VERY DIFFERENT TREATMENTS — voriconazole for one, amphotericin plus urgent surgery for the other.
Laboratory methods and their limits
KOH mount dissolves keratin. SABOURAUD DEXTROSE AGAR is standard, its LOW pH suppressing bacteria. INDIA INK shows the cryptococcal capsule. CALCOFLUOR WHITE binds chitin. PAS and GOMORI METHENAMINE SILVER are the tissue stains. GALACTOMANNAN and BETA-D-GLUCAN detect invasive disease before culture.
BETA-D-GLUCAN IS ABSENT FROM THE MUCORALES AND FROM CRYPTOCOCCUS, so a NEGATIVE RESULT DOES NOT EXCLUDE those two. Cryptococcal ANTIGEN testing is more sensitive than India ink and has largely replaced it.
Dermatophytes
TRICHOPHYTON, MICROSPORUM, EPIDERMOPHYTON. They DIGEST KERATIN and are therefore CONFINED TO SKIN, HAIR AND NAILS. TINEA CAPITIS scalp, CORPORIS body, CRURIS groin, PEDIS foot, UNGUIUM nail.
TOPICAL TREATMENT FAILS FOR SCALP AND NAIL because the fungus resides WITHIN THE HAIR SHAFT AND NAIL PLATE where topical agents cannot penetrate — oral terbinafine or itraconazole is required, and griseofulvin remains useful in childhood tinea capitis.
Resistant dermatophytosis in India
Recurrent and treatment-resistant dermatophytosis is now a major problem, associated with OVER-THE-COUNTER TOPICAL STEROID-ANTIFUNGAL COMBINATIONS that suppress inflammation while allowing spread. TINEA INCOGNITO is the resulting atypical presentation, with the RAISED ACTIVE EDGE LOST.
TRICHOPHYTON INDOTINEAE has been identified as a distinct TERBINAFINE-RESISTANT species carrying SQUALENE EPOXIDASE mutations — target alteration, exactly the resistance mechanism seen in bacteria.
Other superficial infections
MALASSEZIA FURFUR: pityriasis versicolor, hypo- or hyperpigmented macules, SPAGHETTI AND MEATBALLS appearance; LIPOPHILIC, hence distribution over sebum-rich areas and association with neonatal LIPID INFUSIONS. CANDIDA: thrush, intertrigo, vulvovaginitis, nappy rash; favoured by moisture, antibiotics, diabetes, steroids.
ORAL THRUSH IN AN ADULT WITH NO OBVIOUS LOCAL CAUSE should prompt consideration of HIV or another immunodeficiency, since it is otherwise unusual outside infancy and denture use.
Subcutaneous mycoses
Acquired by TRAUMATIC INOCULATION, spreading LOCALLY, not disseminating in immunocompetent hosts. MYCETOMA: chronic swelling with DISCHARGING SINUSES containing GRAINS. EUMYCETOMA is FUNGAL, typically BLACK grains; ACTINOMYCETOMA is BACTERIAL, PALE or RED grains. SPOROTRICHOSIS: thorn prick, LYMPHOCUTANEOUS chain of nodules. CHROMOBLASTOMYCOSIS: verrucous plaques with SCLEROTIC BODIES. RHINOSPORIDIOSIS: friable nasal polyps, pond bathing.
THE GRAIN COLOUR DECIDES BETWEEN ANTIBACTERIAL AND ANTIFUNGAL TREATMENT — actinomycetoma responds to antibiotics while eumycetoma often needs surgery. These matter disproportionately in India because they follow barefoot agricultural work.
The endemic dimorphic fungi
HISTOPLASMA: Ohio and Mississippi valleys AND INDIA (Gangetic plain); INTRACELLULAR in macrophages; bird and bat droppings. BLASTOMYCES: BROAD-BASED budding. COCCIDIOIDES: SPHERULES with endospores; ERYTHEMA NODOSUM indicates a good prognosis. PARACOCCIDIOIDES: PILOT-WHEEL budding. TALAROMYCES MARNEFFEI: Southeast Asia and northeast India, HIV-associated.
These cause SELF-LIMITING pulmonary disease in healthy people and DISSEMINATED disease in the immunosuppressed — the host principle again. HISTOPLASMA SURVIVES INSIDE MACROPHAGES, so it clusters in advanced HIV and anti-TNF therapy and can REACTIVATE years later.
Cryptococcus
ENCAPSULATED yeast acquired by INHALATION; PIGEON DROPPINGS classical source. The POLYSACCHARIDE CAPSULE inhibits phagocytosis and is the principal virulence factor. MENINGITIS occurs almost exclusively at CD4 BELOW 100. Induction: AMPHOTERICIN B with FLUCYTOSINE, then FLUCONAZOLE.
RAISED INTRACRANIAL PRESSURE IS A MAJOR CAUSE OF DEATH and requires REPEATED THERAPEUTIC LUMBAR PUNCTURE, which is as important as the antifungal therapy. Cryptococcal ANTIGEN testing is the preferred diagnostic method.
Aspergillus: one organism, three diseases
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS in asthma and cystic fibrosis, with RAISED IgE and EOSINOPHILIA. ASPERGILLOMA colonising an EXISTING CAVITY. INVASIVE ASPERGILLOSIS in NEUTROPENIA.
THE SAME ORGANISM PRODUCES AN ALLERGIC DISEASE, A COLONISING MASS AND A FATAL INVASIVE INFECTION, DEPENDING ONLY ON THE HOST — the clearest single illustration of this chapter's principle. VORICONAZOLE is preferred for invasive disease and characteristically causes transient visual disturbance.
Mucormycosis and the iron mechanism
Caused by the MUCORALES; characteristically ANGIOINVASIVE, producing tissue INFARCTION and the BLACK NECROTIC ESCHAR of rhino-orbital-cerebral disease. DIABETIC KETOACIDOSIS is classic because ACIDOSIS RELEASES IRON FROM TRANSFERRIN and the organism REQUIRES FREE IRON.
Treatment demands URGENT SURGICAL DEBRIDEMENT alongside amphotericin, since DEAD INFARCTED TISSUE CANNOT BE REACHED BY ANY DRUG. DEFEROXAMINE PARADOXICALLY WORSENS IT, because the organism uses the chelator complex as a SIDEROPHORE. India saw a sharp rise during the COVID-19 pandemic from steroids plus uncontrolled diabetes.
Pneumocystis jirovecii
Pneumonia at CD4 BELOW 200: DRY COUGH, EXERTIONAL DESATURATION, diffuse infiltrates. Treated with CO-TRIMOXAZOLE. Adjunctive CORTICOSTEROIDS when hypoxaemia is significant, because killing the organism RELEASES ANTIGEN and transiently worsens inflammation.
IT LACKS ERGOSTEROL, which is exactly why AMPHOTERICIN AND THE AZOLES DO NOT WORK. It CANNOT BE CULTURED — diagnosis is by induced sputum or lavage with silver or immunofluorescent staining. Raised LDH and beta-D-glucan support it; prophylaxis below CD4 200.
Candida species and their susceptibility
C. ALBICANS: GERM TUBE positive in serum at 37 degrees, CHLAMYDOSPORES on cornmeal agar, generally azole-sensitive. C. GLABRATA: reduced azole susceptibility. C. KRUSEI: INTRINSICALLY FLUCONAZOLE-RESISTANT. C. PARAPSILOSIS: catheter and prosthetic association, reduced echinocandin susceptibility. C. AURIS: MULTIDRUG-RESISTANT, persists on surfaces, causes outbreaks, FREQUENTLY MISIDENTIFIED.
CANDIDAEMIA REQUIRES REMOVAL OF ANY INDWELLING LINE, since biofilm resists all antifungals, plus OPHTHALMOLOGICAL ASSESSMENT for endophthalmitis. A POSITIVE BLOOD CULTURE FOR CANDIDA IS NEVER A CONTAMINANT, unlike coagulase-negative staphylococci.
Antifungal classes and targets
AMPHOTERICIN B: binds ERGOSTEROL, forms pores; NEPHROTOXICITY, POTASSIUM and MAGNESIUM wasting. AZOLES: inhibit LANOSTEROL 14-ALPHA-DEMETHYLASE; inhibit HUMAN CYP. ECHINOCANDINS: inhibit BETA-GLUCAN synthesis. FLUCYTOSINE: converted to 5-FLUOROURACIL in the fungus; MARROW SUPPRESSION. TERBINAFINE: SQUALENE EPOXIDASE. GRISEOFULVIN: microtubules.
ECHINOCANDINS ARE SO WELL TOLERATED BECAUSE BETA-GLUCAN HAS NO HUMAN COUNTERPART AT ALL. Azole CYP inhibition follows directly from the enzyme they were designed to inhibit. FLUCYTOSINE IS NEVER GIVEN ALONE because resistance emerges rapidly.
Why antifungals are harder than antibacterials
FUNGI ARE EUKARYOTES, sharing most cellular machinery with human cells, leaving VERY FEW SELECTIVE TARGETS. Bacteria are prokaryotes with a different ribosome, a peptidoglycan wall and distinct pathways, offering MANY more points of attack.
This is why there are only FOUR main antifungal classes against dozens of antibacterial ones, and why the antifungals that exist tend to be MORE TOXIC. AGRICULTURAL AZOLE FUNGICIDE USE selects for azole-resistant Aspergillus in the environment, so a patient can acquire a resistant strain WITHOUT EVER HAVING TAKEN AN AZOLE.
Choosing an antifungal
AMPHOTERICIN first-line for MUCORMYCOSIS and CRYPTOCOCCAL INDUCTION. ECHINOCANDINS DO NOT WORK against CRYPTOCOCCUS or the MUCORALES, and are a POOR CHOICE FOR URINARY candidiasis (low urinary concentrations — use fluconazole). FLUCONAZOLE penetrates CSF well, used for cryptococcal consolidation. VORICONAZOLE for invasive aspergillosis. ECHINOCANDINS first-line for CANDIDAEMIA.
LIPOSOMAL amphotericin reduces nephrotoxicity substantially but not infusion reactions, and is far more expensive; PRE-MEDICATION and SALINE LOADING remain routine with the conventional formulation.
⚠️

Traps NEET PG sets — and how to dodge them

These are the exact option-traps and misreads that cost marks under negative marking.

WATCH OUT
Treating tinea capitis or onychomycosis with topical agents alone
The organism resides within the hair shaft and nail plate where topical drugs cannot penetrate. Oral terbinafine, itraconazole or griseofulvin is required, and treatment must continue long enough for healthy keratin to grow out.
WATCH OUT
Using an echinocandin for cryptococcal or mucormycotic infection
Neither organism is susceptible to echinocandins. Cryptococcus requires amphotericin with flucytosine for induction, and mucormycosis requires amphotericin plus urgent surgical debridement.
WATCH OUT
Relying on a negative beta-D-glucan to exclude invasive fungal disease
Beta-D-glucan is absent from the cell wall of the Mucorales and of Cryptococcus, so it is negative in exactly two of the most dangerous invasive fungal infections. Imaging and direct sampling are needed.
WATCH OUT
Treating mucormycosis with antifungal therapy alone
The organism is angioinvasive and infarcts the tissue it occupies, so no drug can reach the dead tissue by any route. Urgent surgical debridement is as essential as amphotericin, and delay is the main determinant of mortality.
WATCH OUT
Assuming a positive Aspergillus result means invasive disease
The same organism causes allergic bronchopulmonary aspergillosis in asthmatics, an aspergilloma in an existing cavity, and invasive disease only in neutropenia. The host state determines which, and treatment differs completely.
WATCH OUT
Using an azole or amphotericin for Pneumocystis pneumonia
Pneumocystis lacks ergosterol in its membrane, so both classes have no target. Co-trimoxazole is the treatment and the prophylactic agent, with corticosteroids added when hypoxaemia is significant.
WATCH OUT
Dismissing a blood culture growing Candida as a contaminant
Unlike coagulase-negative staphylococci, Candida in blood is never a contaminant and untreated candidaemia carries high mortality. Line removal, echinocandin therapy and ophthalmological assessment are all required.
WATCH OUT
Prescribing empirical fluconazole where Candida krusei is likely
Candida krusei is intrinsically resistant to fluconazole, and Candida glabrata has reduced susceptibility. An echinocandin is the safer empirical choice in seriously ill patients until species and sensitivities are known.
WATCH OUT
Giving deferoxamine to a patient at risk of mucormycosis
The Mucorales use the deferoxamine-iron complex as a siderophore, taking up the iron it delivers, so chelation paradoxically feeds the organism. Alternative chelators without this property are used where iron removal is necessary.

Exam-pattern practice

PYQ-style questions with full solutions. Work through them as a readiness check — mark yourself honestly and get your gap report at the end.

Readiness check

Are you exam-ready for Mycology?

9 problems from this chapter. Try each one, reveal the worked solution, mark yourself honestly — get your gap report at the end.

9 questions~6 min

5-minute revision

The whole chapter, distilled. Read this the night before the exam.

  • The host, not the fungus, decides the disease; identify the failed defence first.
  • Neutrophils control moulds; T cells control yeasts and intracellular fungi.
  • Ergosterol resembles cholesterol, giving both selectivity and toxicity to amphotericin and azoles.
  • Dimorphic fungi are mould at ambient temperature and yeast at body temperature.
  • Acute-angle septate hyphae are Aspergillus; right-angle aseptate hyphae are Mucorales.
  • Beta-D-glucan is negative in Mucorales and Cryptococcus infection.
  • Dermatophytes digest keratin and cannot invade beyond it in immunocompetent hosts.
  • Scalp and nail infections need systemic therapy because the organism is inside hair and nail.
  • Topical steroid-antifungal combinations have driven resistant dermatophytosis and tinea incognito.
  • Trichophyton indotineae carries squalene epoxidase mutations conferring terbinafine resistance.
  • Malassezia is lipophilic, hence sebum-rich distribution and the lipid infusion association.
  • Mycetoma grain colour separates fungal eumycetoma from bacterial actinomycetoma.
  • Sporotrichosis spreads along lymphatics in a characteristic chain of nodules.
  • Histoplasma survives inside macrophages and is endemic in the Gangetic plain.
  • Cryptococcal meningitis occurs below CD4 100, and raised pressure must be treated by repeated lumbar puncture.
  • Aspergillus causes allergic, colonising and invasive disease depending only on the host.
  • Ketoacidosis liberates transferrin-bound iron, which is why it predisposes to mucormycosis.
  • Deferoxamine worsens mucormycosis because the organism uses it as a siderophore.
  • Mucormycosis requires surgical debridement because infarcted tissue receives no drug.
  • Pneumocystis lacks ergosterol and responds to co-trimoxazole, not to antifungals.
  • Candida krusei is intrinsically fluconazole-resistant; Candida auris is multidrug-resistant.
  • Candida in blood is never a contaminant, and the line must be removed.
  • Echinocandins fail against Cryptococcus, Mucorales and urinary candidiasis.
  • Antifungals are few and toxic because fungi are eukaryotes sharing our cellular machinery.

NEET PG question blueprint

How this topic is asked, tier by tier — so you can prep to the pattern.

Typical weightage: Each NEET PG question is worth +4/-1; mycology contributes around 2 questions per attempt and recurs in Medicine, Dermatology and Pediatrics stems

Question styleMarks eachTypical countWhat it tests
Superficial and subcutaneous4~1Dermatophyte sites and treatment, resistant dermatophytosis, Malassezia, mycetoma, sporotrichosis and other subcutaneous mycoses
Invasive moulds and yeasts4~1Host-organism associations, Aspergillus spectrum, mucormycosis and the iron mechanism, Cryptococcus, Pneumocystis, Candida species
Antifungal therapy4~1Drug targets and selectivity, choosing between classes, resistance, diagnostic biomarkers and their limits
Prep strategy
  • First pass: learn the host defect to organism table, since it answers a large share of mycology questions directly.
  • Second pass: fix the morphological discriminators and the drug target table, both of which are pure recall.
  • Final pass: work the mechanism questions the exam favours — iron in mucormycosis, ergosterol absence in Pneumocystis, beta-D-glucan limitations, and the Aspergillus spectrum.

Exam-hall strategy

Battle-tested tips from mentors and toppers for this topic under the sectional clock.

  1. Identify the host defect in the stem before considering any organism; it usually names the fungus for you.
  2. For mould questions, use hyphal morphology and branching angle, which separates the two major invasive moulds definitively.
  3. In HIV stems, read the CD4 count, since it determines which fungal infections are even possible.
  4. When a biomarker is negative but suspicion is high, check whether the organism lacks that cell wall component.
  5. For dermatophyte questions, ask whether the site is one topical therapy can reach.
  6. In treatment questions, check whether surgery is part of the answer, since mucormycosis is the standing example.
  7. With NEET PG's +4/-1 marking, the host-to-organism associations are reliable recall and among the fastest marks in microbiology.
  8. Under the 5-group, 42-minute time-bound format, mycology items are usually short; answer them quickly to protect time for longer bacteriology and virology stems, since a closed group cannot be reopened.

Beyond the exam

Where this skill shows up in the job you're competing for — and in life.

Empirical antifungal therapy in neutropenic fever

Persistent fever despite broad-spectrum antibiotics in a neutropenic patient triggers empirical antifungal therapy, and the choice depends on which moulds are plausible.

Managing the Indian dermatophytosis epidemic

Recognising steroid-driven tinea incognito and terbinafine resistance changes both the diagnosis and the duration and choice of therapy in a very common presentation.

Rhino-orbital mucormycosis pathways

The COVID-19-associated surge prompted rapid referral pathways in India, because time to surgical debridement is the main determinant of survival.

Infection control for Candida auris

Its persistence on surfaces and resistance to routine disinfection has forced changes in cleaning protocols and patient screening in intensive care units.

Where else this topic is tested

Prepare once, score in every exam that asks it.

USMLE Step 1High overlap — fungal morphology, dimorphism and opportunistic infection are core Step 1 content
FMGE / NExTVery high overlap, with additional emphasis on dermatophytosis and endemic Indian mycoses
MD Microbiology and MD Dermatology entranceFoundational — assumed working knowledge, with identification and antifungal susceptibility examined in far greater depth

Questions aspirants ask

Pulled from the Q&A community and mentor sessions.

Because the fungi are almost all environmental organisms that everybody encounters and almost nobody gets sick from. The variable in the equation is not exposure but defence. A stem describing prolonged neutropenia is telling you to think of invasive moulds; one describing a CD4 count of 50 is telling you to think of Cryptococcus and Pneumocystis; one describing ketoacidosis is pointing at mucormycosis. You can usually name the likely organism before the stem has mentioned any microbiology at all.

Because fungi are eukaryotes and we are too. Bacteria differ from us fundamentally — a different ribosome, a peptidoglycan wall, distinct metabolic pathways — which offers dozens of targets present in the pathogen and absent in the host. Fungi share most of their cellular machinery with human cells, so there are only a handful of exploitable differences: the ergosterol membrane, the beta-glucan and chitin wall, and a few enzymes. That scarcity is also why antifungals are on average more toxic than antibacterials.

Its angioinvasiveness. The organism grows into blood vessels and thromboses them, so the tissue it occupies infarcts. Dead tissue has no blood supply, which means no antifungal drug given by any route can reach the organism living within it. Amphotericin can only protect the viable margin. That is why surgical debridement is not an adjunct but a core part of treatment, and why delay in operating is the strongest predictor of death.

Enough to recognise why it is different. It behaves more like a resistant bacterium than a typical fungus: it colonises skin rather than gut, survives on hospital surfaces for weeks, resists routine disinfectants, spreads between patients, and is frequently resistant to multiple antifungal classes. It is also commonly misidentified by conventional laboratory methods, which is part of why outbreaks are recognised late. A stem describing a hospital cluster of resistant candidaemia is describing this organism.
Header Logo